Yazan Abou-Ismail: Contributing to the Future of von Willebrand Disease Management
Yazan Abou-Ismail, Associate Professor of Hematology at the University of Utah, shared a post on LinkedIn:
“Finally arrived..! My very first book chapter in a medical textbook.
Quite honored to be included among such an esteemed list of colleagues and world renowned hematologists, and very grateful to the editors and most importantly my coauthor and mentor of 10 years Peter Kouides, (who also was my mentor on my very first peer-reviewed journal publication in 2018.)
In this chapter we detail the expert management of von Willebrand Disease, the most common hereditary bleeding disorder, in different clinical settings including perioperative, obstetrical, cardiovascular and unique scenarios.
This took a huge amount of work and I’m quite excited to finally see it in hard cover! Now available with Springer Nature.”
Stay updated with Hemostasis Today.
-
Jul 9, 2026, 19:00Wolfgang Miesbach: ISTH 2026 Showcases the Future of Gene Therapy
-
Jul 9, 2026, 18:21Martin Vanden Eede: Can We Safely Reduce Anticoagulation During ECMO?
-
Jul 9, 2026, 18:00Dorothée Faille: Discovering Versailles During ISTH 2026
-
Jul 9, 2026, 16:45Rutbaa Ayaz Shaikh: One Step Further in Medical Research
-
Jul 9, 2026, 14:49Celebrating a Century of von Willebrand Disease Research and Care – Seminars in Thrombosis and Hemostasis
-
Jul 9, 2026, 14:38Valance Washington: International Hemostasis Community Prepares for GRC 2026
-
Jul 9, 2026, 14:27Dima Shulkin: Next-Generation AI Models Improve Early Sepsis Recognition
-
Jul 9, 2026, 14:12Omar Hajji: Seasonal Determinants of Mortality in Sepsis and Cardiogenic Shock
-
Jul 9, 2026, 13:54Hussein Yassine: Why Omega-3s May Fall Short in Preventing Alzheimer’s Disease